Last updated: 18 July 2019 at 4:18pm EST

Alain Schreiber Net Worth




The estimated Net Worth of Alain Schreiber is at least $17.8 Million dollars as of 18 February 2014. Alain Schreiber owns over 333,333 units of Eagle Pharmaceuticals Inc stock worth over $17,795,188 and over the last 11 years Alain sold EGRX stock worth over $0.

Alain Schreiber EGRX stock SEC Form 4 insiders trading

Alain has made over 1 trades of the Eagle Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Alain bought 333,333 units of EGRX stock worth $4,999,995 on 18 February 2014.

The largest trade Alain's ever made was buying 333,333 units of Eagle Pharmaceuticals Inc stock on 18 February 2014 worth over $4,999,995. On average, Alain trades about 66,667 units every 0 days since 2014. As of 18 February 2014 Alain still owns at least 4,770,828 units of Eagle Pharmaceuticals Inc stock.

You can see the complete history of Alain Schreiber stock trades at the bottom of the page.



What's Alain Schreiber's mailing address?

Alain's mailing address filed with the SEC is C/O PROQUEST INVESTMENTS, L.P., 2430 VANDERBILT BEACH ROAD, 108-190, NAPLES, FL, 34109.

Insiders trading at Eagle Pharmaceuticals Inc

Over the last 11 years, insiders at Eagle Pharmaceuticals Inc have traded over $188,911,314 worth of Eagle Pharmaceuticals Inc stock and bought 1,029,065 units worth $16,655,732 . The most active insiders traders include Executive Capital Lphec Man..., Douglas L Braunstein, and Investments Iv, L.P.Pro Que.... On average, Eagle Pharmaceuticals Inc executives and independent directors trade stock every 43 days with the average trade being worth of $193,721. The most recent stock trade was executed by Scott Tarriff on 1 November 2023, trading 21,619 units of EGRX stock currently worth $299,207.



What does Eagle Pharmaceuticals Inc do?

specialty pharmaceutical company



Complete history of Alain Schreiber stock trades at Eagle Pharmaceuticals Inc

Insider
Trans.
Transaction
Total value
Alain Schreiber
Director
Buy $4,999,995
18 Feb 2014


Eagle Pharmaceuticals Inc executives and stock owners

Eagle Pharmaceuticals Inc executives and other stock owners filed with the SEC include: